Spravato
Articles tagged with “Spravato”
CBT After Esketamine Boosts Depression Outcomes in Trial
A new randomized trial finds that adding 16 weeks of CBT after esketamine significantly improves depression and suicidal ideation compared to esketamine alone.
Why Patients Quit NMDA Therapy—And What Providers Should Do
New clinical review urges faster dose optimization and earlier switching between NMDA therapies for treatment-resistant depression. Here's what it means for patients.
NMDA Side Effects: What Dropout Rates Mean for Patients
New clinical guidance on NMDA antagonist side effects and dropout rates offers practical insights for patients considering ketamine or esketamine therapy.
Ketamine Side Effects: What New Data Tells Patients
A new clinical review examines side effect profiles and discontinuation rates for NMDA antagonists like ketamine and esketamine. Here's what patients should know.
Ketamine Side Effects: What New Data Means for Patients
New clinical guidance on NMDA antagonist side effects and discontinuation rates gives patients and families sharper questions to ask before starting ketamine therapy.
How Doctors Choose Ketamine vs. Other TRD Treatments
New clinical guidance explains how psychiatrists choose between esketamine, ketamine, and brain stimulation for treatment-resistant depression patients.
Esketamine's Role in Treatment-Resistant Depression Care
Where esketamine (Spravato) sits in 2026 treatment-resistant depression care: FDA-approved indications, response rates after SSRI failure, access barriers, and how it compares to generic IV and at-home options.
Generic Ketamine vs Spravato: Comparing Off-Label and FDA-Approved Options
Side-by-side comparison of generic racemic ketamine and Spravato (esketamine) nasal spray: per-session cost, insurance coverage, FDA approval status, and what generic availability looks like in 2026.
What Is the Difference Between Ketamine and Esketamine?
What is the difference between ketamine and esketamine? Learn how these related molecules compare in terms of chemistry, effectiveness, cost, and availability.
Navigating Insurance Coverage for Ketamine Therapy
Does insurance cover ketamine therapy or Spravato in 2026? Coverage rules, prior authorization tips, appeal strategies, and out-of-pocket reality.
What a Spravato (Esketamine) Nasal Spray Session Is Really Like
Curious what a Spravato (esketamine) session is really like? A patient walks through the spray, the 2-hour monitoring, and the comedown sensations.
Does Insurance Cover Ketamine Therapy?
A guide to understanding insurance coverage for ketamine therapy — what is covered, what is not, how Spravato differs, and strategies for managing out-of-pocket costs.
How Long Does a Ketamine Therapy Session Last?
How long does a ketamine session last? Learn about session duration for IV infusions, Spravato, sublingual ketamine, and what affects your total time commitment.
IV vs. Oral vs. Nasal Spray Ketamine: Comparing Your Options
Side-by-side comparison of IV infusion, oral/sublingual, and Spravato nasal spray ketamine: per-session cost, bioavailability, onset, side-effect profile, and which format fits which depression treatment goal.
Need help or want to reach readers?
Have a correction, provider question, or advertising inquiry? Reach the editorial team.